Sign in

CIK 0001607678 · Large accelerated filer

Viking Therapeutics, Inc.

Sign in to watch
Ticker
VKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
461073877
Phone
858-704-4660
Business address
9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
  1. DEF 14A Proxy Proxy Statement
  2. EFFECT Other Notice of Effectiveness
  3. 424B3 Offering Prospectus
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. CT ORDER Other Confidential Order
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. UPLOAD Other SEC-generated Letter
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 8-K Event Material agreement · Unregistered share sale
  13. S-3 Offering Registration Statement
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy Director bought 13,000 shares at $1.21 ($15,678)

Page 26 of 33 · 652 filings